| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
13,933,000 | 12,241,000 | 11,102,000 | 9,917,000 | 8,399,000 |
|
Cost of Revenue
|
-2,352,000 | -2,086,000 | -1,878,000 | -1,703,000 | -1,499,000 |
|
Gross Profit
|
11,581,000 | 10,155,000 | 9,224,000 | 8,214,000 | 6,900,000 |
| Selling, General and Administrative Expenses
|
-4,477,000 | -3,930,000 | -3,333,000 | -3,788,000 | -2,466,000 |
|
Research and Development Expenses
|
-2,563,000 | -2,354,000 | -2,056,000 | -1,722,000 | -1,502,000 |
| Other Income/Expense, Operating
|
-1,407,000 | -1,327,000 | -1,282,000 | -1,186,000 | -1,041,000 |
|
Operating Income/Expenses
|
-8,447,000 | -7,611,000 | -6,671,000 | -6,696,000 | -5,009,000 |
|
Total Operating Profit/Loss
|
3,134,000 | 2,544,000 | 2,553,000 | 1,518,000 | 1,891,000 |
| Total Net Finance Income/Expense
|
596,000 | 705,000 | 818,000 | 721,000 | 186,000 |
| Irregular Income/Expenses
|
0 | -- | 0 | 0 | -89,000 |
|
Other Income/Expense, Non-Operating
|
14,000 | -112,000 | -40,000 | -137,000 | 1,000 |
|
Non-Operating Income/Expenses, Total
|
610,000 | 593,000 | 778,000 | 584,000 | 98,000 |
|
Pretax Income
|
3,744,000 | 3,137,000 | 3,331,000 | 2,102,000 | 1,989,000 |
|
Provision for Income Tax
|
-537,000 | -626,000 | -683,000 | 2,690,000 | -96,000 |
|
Net Income from Continuing Operations
|
3,207,000 | 2,511,000 | 2,648,000 | 4,792,000 | 1,893,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
3,207,000 | 2,511,000 | 2,648,000 | 4,792,000 | 1,893,000 |
|
Net Income after Non-Controlling/Minority Interests
|
3,207,000 | 2,511,000 | 2,648,000 | 4,792,000 | 1,893,000 |
|
Net Income Available to Common Stockholders
|
3,207,000 | 2,511,000 | 2,648,000 | 4,792,000 | 1,893,000 |
|
Dilution to Earnings
|
1,000 | 3,000 | 4,000 | 3,000 | -- |
|
Diluted Net Income Available to Common Stockholders
|
3,208,000 | 2,514,000 | 2,652,000 | 4,795,000 | 1,893,000 |
| Basic EPS
|
5.39 | 4.10 | 4.19 | 7.52 | 2.97 |
| Diluted EPS
|
5.33 | 4.03 | 4.11 | 7.24 | 2.79 |
|
Basic Weighted Average Shares Outstanding
|
595,750 | 613,000 | 632,000 | 637,000 | 637,000 |
|
Diluted Weighted Average Shares Outstanding
|
603,500 | 623,000 | 645,000 | 662,000 | 680,000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
3,148,000 | 2,432,000 | 2,513,000 | 1,381,000 | 1,803,000 |
|
EBITDA
|
3,148,000 | 2,432,000 | 2,513,000 | 1,381,000 | 1,884,000 |
|
Normalized EBITDA
|
5,075,000 | 4,297,000 | 4,041,000 | 3,653,000 | 2,903,000 |
|
Normalized Income
|
4,723,130.67 | 3,784,600 | 3,766,565 | 5,623,376 | 2,949,720 |
|
Total Unusual Items
|
1,770,000 | 1,592,000 | 1,407,000 | 1,120,000 | 1,110,000 |
12/31/2022 - 12/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade